# GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups

> **NCT00909051** · — · COMPLETED · sponsor: **Bayer** · enrollment: 15729 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Acarbose (Glucobay, BAYG5421)

## Key facts

- **NCT ID:** NCT00909051
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03-24
- **Primary completion:** 2010-12-31
- **Final completion:** 2010-12-31
- **Target enrollment:** 15729 (ACTUAL)
- **Last updated:** 2023-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00909051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00909051, "GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00909051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*